In 2024, small and mid-sized life sciences, biotech, and pharmaceutical companies face an increasingly perilous cybersecurity landscape. As these organizations become more digital and interconnected, they are prime targets for cybercriminals. This article outlines the key cybersecurity threats in life sciences that these companies encounter and provides actionable steps for mitigating these risks.
To defend against these threats, small and mid-sized pharmaceutical companies should implement a comprehensive cybersecurity strategy that includes the following steps:
Statistics indicate that small and mid-sized pharma companies are increasingly at risk:
– A survey found that 60% of life sciences organizations experienced a cyber incident in the last year, with many reporting multiple attacks.
– The global average cost of a data breach is approximately $4.35 million, with healthcare organizations experiencing even higher costs due to regulatory penalties.
As the digital landscape evolves, so too do the tactics employed by cybercriminals. It is imperative for small and mid-sized life sciences companies to adopt proactive measures now to safeguard their operations against future threats. By investing in cybersecurity infrastructure and fostering a culture of security awareness, organizations can protect their valuable assets and maintain trust with stakeholders in an increasingly complex environment.